Kobayashi, Miwako
Centers for Disease Control and Prevention
7 papers on CoChatORCID 0000-0002-9190-5619
Most cited papers
- Verified
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
Lauring, A. S., Tenforde, M. W., Chappell, J. D., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., et al. (2022) · BMJ
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 656
- Verified
Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity
Tenforde, M. W., Self, W. H., Adams, K., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., et al. (2021) · JAMA
SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Cited by 633
- Verified
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
Self, W. H., Tenforde, M. W., Rhoads, J. P., Gaglani, M., Ginde, A. A., Douin, D. J., Olson, S. M., Talbot, H. K., Casey, J. D., Mohr, N. M., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy
Cited by 406
- Verified
Use of 15-valent pneumococcal conjugate vaccine and 20-valent pneumococcal conjugate vaccine among U.S. Adults: Updated recommendations of the Advisory Committee on Immunization Practices - United States, 2022
Kobayashi, M., Farrar, J. L., Gierke, R., Britton, A., Childs, L., Leidner, A. J., Campos-Outcalt, D., Morgan, R. L., Long, S. S., Talbot, H. K., et al. (2022) · MMWR. Morbidity and Mortality Weekly Report
Pneumonia and Respiratory InfectionsBacterial Infections and Vaccines
Cited by 352
- Verified
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021
Tenforde, M. W., Self, W. H., Naioti, E. A., Ginde, A. A., Douin, D. J., Olson, S. M., Talbot, H. K., Casey, J. D., Mohr, N. M., Zepeski, A., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy
Cited by 204
- Verified
WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27–28 April 2016
Kobayashi, M., Schrag, S. J., Alderson, M. R., Madhi, S. A., Baker, C. J., Sobanjo-ter Meulen, A., Kaslow, D. C., Smith, P. G., Moorthy, V. S., & Vekemans, J. (2019) · Vaccine
Neonatal and Maternal InfectionsBacterial Infections and Vaccines
Cited by 105
- Verified
Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines
Lewnard, J. A., Patel, M. M., Jewell, N. P., Verani, J. R., Kobayashi, M., Tenforde, M. W., Dean, N. E., Cowling, B. J., & Lopman, B. A. (2021) · Epidemiology
SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies
Cited by 103
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free